| |
siRNA Id: | aspsirna0904
|
siRNA Name: | Sibeta2m01
|
Gene: | Beta 2-microglobulin (B2M) |
Disease: | HLA incompatibility |
Wild allele/target (5'->3'): | AAAGUGGAGCAUUCAGACU
|
Mutant allele/target (5'->3'): | AAAGUGGAGCAUUCACACU
|
Target Mutation: | c.31G>C,p.Ala11Pro
|
Wild siRNA (As strand): | UUUCACCUCGUAAGUCUGA
|
ASP-siRNA (As strand): | UUUCACCUCGUAAGUGUGA
|
Mismatch position in siRNA: | G4C |
Mutant allele (5'->3'): | AAAGUGGAGCAUUCACACU
|
ASP-siRNA (As strand): | UUUCACCUCGUAAGUGUGA
|
ASP-siRNA efficacy for mutant allele: | 90
|
Wild allele (5'->3'): | AAAGUGGAGCAUUCAGACU
|
ASP-siRNA (As strand): | UUUCACCUCGUAAGUGUGA
|
ASP-siRNA efficacy for wild allele: | NA
|
Percentage discrimination for ASP-siRNA: | NA
|
Wild allele (5'->3'): | AAAGUGGAGCAUUCAGACU
|
Wild siRNA (As strand): | UUUCACCUCGUAAGUCUGA
|
Wild sirna efficacy for wild allele: | 50
|
Wild allele (5'->3'): | AAAGUGGAGCAUUCAGACU
|
ASP-siRNA (As strand): | UUUCACCUCGUAAGUGUGA
|
Wild sirna efficacy for mutant allele: | 90
|
Percentage discrimination for wild siRNA: | -40
|
Concentration: | 1.2mIcrog |
Orientation: | Double strand |
Mismatch in: | siRNA |
UniProt ID: | P61769 |
Target sequence: | ATTGAAAAAGTGGAGCATTCAGACT |
Genbank Accesion: | NM_004048.2 |
Cell-line: | Epstein–Barr-virus-immortalized B-lymphocytes |
Experimental technique used: | Western blot |
Transfection method: | RNAiFect |
siRNA expression method: | Ambion |
Post-transfection duration: | 48 hours |
OMID ID: | NA |
KEGG disease ID: | NA |
Reference: | 16520945 |